Doctors are decreasing the use of hip replacements such as the Stryker Rejuvenate and Stryker ABG II metal-on-metal hip replacements due to safety issues. Many manufacturers have recalled metal-on-metal hip implants after studies have shown the hip devices are more likely to fail than alternatives.
The Stryker Rejuvenate, ABG II and other metal hip devices used to account for 20% of all medical devices sold in 2007, but that number has since declined to less than 2%. Patients have complained of metal-on-metal hip replacement side effects such as tissue damage, loosened hip joints, toxic levels of metal in the bloodstream and limited mobility.
Stryker could face many Rejuvenate and ABG II lawsuits after issuing a hip implant recall in July 2012. Many Stryker patients have had to undergo revision surgery to fix complications from the metal hip devices.